GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mountain Valley MD Holdings Inc (FRA:20MP) » Definitions » 3-Year Dividend Growth Rate

Mountain Valley MD Holdings (FRA:20MP) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Mountain Valley MD Holdings 3-Year Dividend Growth Rate?

Mountain Valley MD Holdings's Dividends per Share for the three months ended in Dec. 2023 was €0.00.

The historical rank and industry rank for Mountain Valley MD Holdings's 3-Year Dividend Growth Rate or its related term are showing as below:

FRA:20MP's 3-Year Dividend Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 11
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Mountain Valley MD Holdings's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, Mountain Valley MD Holdings's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Mountain Valley MD Holdings's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Mountain Valley MD Holdings's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mountain Valley MD Holdings's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mountain Valley MD Holdings's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Mountain Valley MD Holdings's 3-Year Dividend Growth Rate falls into.



Mountain Valley MD Holdings 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Mountain Valley MD Holdings  (FRA:20MP) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Mountain Valley MD Holdings's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ 0.001
=0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mountain Valley MD Holdings 3-Year Dividend Growth Rate Related Terms>


Mountain Valley MD Holdings (FRA:20MP) Business Description

Traded in Other Exchanges
Address
260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm along with its subsidiaries is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The Quicksome desiccation technology utilizes liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats that are consumed orally.

Mountain Valley MD Holdings (FRA:20MP) Headlines

No Headlines